분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-08-03 16:50:33 , Hit : 1036
 “Kissing Disease” Virus Promotes Malignant Breast Cancer Development

GEN News Highlights
More »
Aug 2, 2016


Researchers have found that infection with the Epstein-Barr virus (pictured) may put some women at increased risk for developing breast cancer. [NIH]


In our adolescent years, we would often snicker at other kids who were diagnosed with mononucleosis, as it was (and often still is) colloquially referred to as the “kissing disease.” However, in recent years mounting evidence has suggested that infection with Epstein-Barr virus (EBV) has become associated with various forms of cancer—which is certainly no laughing matter.

Alarmingly, a new study led by researchers from the Beth Israel Deaconess Medical Center (BIDMC) has revealed that infection with EBV may put some women at increased risk of developing breast cancer. Yet, results from the new study—“Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation”—published recently in EBioMedicine, may provide important implications for breast cancer screening and prevention in the future.

EBV, one of eight known viruses in the herpes family (human herpes 4 or HHV4) to infect humans, is also one of the most common viruses to infect humans and is best known as the cause of infectious mononucleosis. Although more than 90% of the world's population carries EBV, most individuals experience no effects from infection. Nonetheless, in certain individuals, EBV has been linked to various cancers, including African Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma, gastric adenocarcinoma, and leiomyosarcoma.

Some more recent studies have tied EBV infection to breast cancer, yet it's unclear how the virus may play a role in breast cancer development and/or progression. To investigate EBV’s role in breast cancer development, researchers cultured breast cells called primary mammary epithelial cells (MECs) in the presence of the virus.

The authors wrote that "EBV can infect primary MECs that express the receptor CD21. EBV infection leads to the expansion of early MEC progenitor cells with a stem cell phenotype, activates MET signaling and enforces a differentiation block. When MECs were implanted as xenografts, EBV infection cooperated with activated Ras and accelerated the formation of breast cancer.”

Interestingly, when the investigators subsequently analyzed the genes of MECs infected with EBV, they found genetic characteristics associated with high-grade, estrogen-receptor-negative breast cancer (an aggressive form of the disease).

"We think that if a young woman develops EBV during her teenage years or later, her breast, epithelial cells will be exposed to the virus and can be infected. While for most individuals, there will be no long-term consequences, in some the infection may leave genetic scars and change the metabolism of these cells," explained senior study author Gerburg Wulf, M.D., Ph.D., physician scientist in the hematology/oncology division at BIDMC and associate professor of medicine at Harvard Medical School. "While these are subtle changes, they may decades later, facilitate breast cancer formation."

The researchers feel their findings establish a close link between EBV influencing the development of malignant breast cancer.

“We conclude that a contribution of EBV to breast cancer etiology is plausible, through a mechanism in which EBV infection predisposes mammary epithelial cells to malignant transformation, but is no longer required once malignant transformation has occurred,” the authors stated.

Dr. Wulf added that his team’s findings "further make the case for an EBV vaccine that might protect children from infection and later EBV-associated malignancies."







1147   DNA Can Be Edited Without Being Cut  이성욱 2016/08/30 1416
1146   Using RNA to Amplify RNA  이성욱 2016/08/16 1030
1145   CRISPR: No Cutting Required  이성욱 2016/08/06 1634
  “Kissing Disease” Virus Promotes Malignant Breast Cancer Development  이성욱 2016/08/03 1036
1143   Lytic and latent viral replication prevented with CRISPR/Cas9  이성욱 2016/07/27 916
1142   Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time  이성욱 2016/07/27 1090
1141   FDA OKs AbbVie's once-daily Viekira XR for HCV-1  이성욱 2016/07/27 903
1140   [미국] 유전자가위 규제 마련 지연과 기업들의 움직임  이성욱 2016/07/21 1100
1139   5년새 20배 성장 `유전자치료제` 시장..경쟁력 확보 필수  이성욱 2016/07/21 985
1138   Revisiting CAR T-Cells for Treating HIV Shows Promise  이성욱 2016/07/19 790
1137   코오롱, 유전자치료제 판매 허가 신청  이성욱 2016/07/12 893
1136   Gilead wins U.S. nod for drug for all types of hepatitis C  이성욱 2016/06/30 967
1135   줄기세포·유전자치료제 차세대 주자로 급부상  이성욱 2016/06/21 1123
1134   Virus Hacks Host Genome, Steals CRISPR to Protect Itself  이성욱 2016/06/16 834
1133   CRISPR Antidotes Galore  이성욱 2016/06/14 1028
1132   Let’s Synthesize the Human Genome, Says HGP-Write  이성욱 2016/06/04 849
1131   A New CRISPR System for RNA  이성욱 2016/06/04 933
1130   Scientists identify a novel CRISPR system that zeroes in on single-stranded RNA.  이성욱 2016/06/04 834
1129   GSK gets EU approval for first gene therapy for children  이성욱 2016/05/30 871
1128   Gene therapy drug approval granted to GSK  이성욱 2016/05/30 931

[1][2][3][4][5][6] 7 [8][9][10]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN